WO2007061741A3 - Modulators of the h3 receptor useful for the treatment of disorders related thereto - Google Patents
Modulators of the h3 receptor useful for the treatment of disorders related thereto Download PDFInfo
- Publication number
- WO2007061741A3 WO2007061741A3 PCT/US2006/044479 US2006044479W WO2007061741A3 WO 2007061741 A3 WO2007061741 A3 WO 2007061741A3 US 2006044479 W US2006044479 W US 2006044479W WO 2007061741 A3 WO2007061741 A3 WO 2007061741A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- treatment
- pharmaceutical compositions
- modulators
- syndrome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006316609A AU2006316609A1 (en) | 2005-11-17 | 2006-11-16 | Modulators of the H3 receptor useful for the treatment of disorders related thereto |
JP2008541338A JP2009515989A (en) | 2005-11-17 | 2006-11-16 | Histamine H3 receptor modulators useful for the treatment of histamine H3-related disorders |
CA002628527A CA2628527A1 (en) | 2005-11-17 | 2006-11-16 | Modulators of the h3 receptor useful for the treatment of disorders related thereto |
EP06837763A EP1948605A2 (en) | 2005-11-17 | 2006-11-16 | Modulators of the h3 receptor useful for the treatment of disorders related thereto |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73762405P | 2005-11-17 | 2005-11-17 | |
US60/737,624 | 2005-11-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007061741A2 WO2007061741A2 (en) | 2007-05-31 |
WO2007061741A3 true WO2007061741A3 (en) | 2007-08-23 |
Family
ID=38067744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/044479 WO2007061741A2 (en) | 2005-11-17 | 2006-11-16 | Modulators of the h3 receptor useful for the treatment of disorders related thereto |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1948605A2 (en) |
JP (1) | JP2009515989A (en) |
CN (1) | CN101365678A (en) |
AU (1) | AU2006316609A1 (en) |
CA (1) | CA2628527A1 (en) |
WO (1) | WO2007061741A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1849772A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
TWI475015B (en) | 2010-03-11 | 2015-03-01 | Sumitomo Dainippon Pharma Co Ltd | N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
CN102952139B (en) * | 2011-08-30 | 2016-08-10 | 上海药明康德新药开发有限公司 | Trans-3a-fluoropyrrolidine [3,4-C] cycle compound and preparation method thereof |
CN104114538B (en) * | 2012-01-16 | 2016-04-13 | 葛兰素史克知识产权发展有限公司 | Therepic use |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012214A2 (en) * | 2000-08-08 | 2002-02-14 | Ortho Mcneil Pharmaceutical Inc. | Non-imidazole aryloxyalkylamines as h3 receptor ligands |
-
2006
- 2006-11-16 JP JP2008541338A patent/JP2009515989A/en not_active Withdrawn
- 2006-11-16 WO PCT/US2006/044479 patent/WO2007061741A2/en active Application Filing
- 2006-11-16 CN CNA2006800482243A patent/CN101365678A/en active Pending
- 2006-11-16 CA CA002628527A patent/CA2628527A1/en not_active Abandoned
- 2006-11-16 EP EP06837763A patent/EP1948605A2/en not_active Withdrawn
- 2006-11-16 AU AU2006316609A patent/AU2006316609A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012214A2 (en) * | 2000-08-08 | 2002-02-14 | Ortho Mcneil Pharmaceutical Inc. | Non-imidazole aryloxyalkylamines as h3 receptor ligands |
Non-Patent Citations (2)
Title |
---|
CELANIRE ET AL: "Keynote review: Histamine H3 receptor antagonists reach out for the clinic", DDT - DRUG DISCOVERY TODAY, ELSEVIER SCIENCE LTD, GB, vol. 10, no. 23-24, December 2005 (2005-12-01), pages 1613 - 1627, XP005222014, ISSN: 1359-6446 * |
STARK H: "Recent advances in histamine H3/H4 receptor ligands", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, vol. 13, no. 6, 2003, pages 851 - 865, XP002298271, ISSN: 1354-3776 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007061741A2 (en) | 2007-05-31 |
CA2628527A1 (en) | 2007-05-31 |
CN101365678A (en) | 2009-02-11 |
EP1948605A2 (en) | 2008-07-30 |
JP2009515989A (en) | 2009-04-16 |
AU2006316609A1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009004071A (en) | Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto. | |
MX2009012430A (en) | Di-substituted amides for enhancing glutamatergic synaptic responses. | |
WO2008153958A3 (en) | Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto | |
MX2010002890A (en) | 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses. | |
WO2009023126A3 (en) | Bicyclic amides for enhancing glutamatergic synaptic responses | |
NZ573565A (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
NO20082264L (en) | Histamine-3 receptor antagonists | |
WO2007088450A3 (en) | Chromane antagonist of the h-3 receptor | |
WO2007105053A3 (en) | Tetralines antagonists of the h-3 receptor | |
NZ595625A (en) | Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators | |
WO2007061741A3 (en) | Modulators of the h3 receptor useful for the treatment of disorders related thereto | |
FI2841431T4 (en) | Dihydrate of benzothiophene compound and process for producing the same | |
WO2007063385A3 (en) | Spirocyclic amine histamine-3 receptor antagonists | |
NZ617334A (en) | Cyclopropyl amine derivatives | |
MX2011007774A (en) | Isoxazole-isoxazole and isoxazole-isothiazole derivatives. | |
MX2011011489A (en) | Isoxazole-pyridine derivatives. | |
EA201071083A1 (en) | ARYLSULPHONYLPYRAZOLINCARBOXAMIDINE DERIVATIVES AS ANTAGONISTS OF 5-NT | |
MX2011011273A (en) | Isoxazole-pyrazole derivatives. | |
PT2221298E (en) | Phenylpyrazole derivatives | |
MX2011008336A (en) | Dihydroquinolinone derivatives. | |
EA200801302A1 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF CNS DISORDERS | |
JP2010529130A5 (en) | ||
NZ614567A (en) | Novel compounds as histamine h3 receptor ligands | |
DOP2011000130A (en) | 1- (ARILSULFONIL) -4- (PEPIRAZIN-1-IL) -1H-BENZIMIDAZOL AS BINDING WITH 5-HYDROXITRIPTAMINE-6 | |
JP2008519056A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680048224.3 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006837763 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2628527 Country of ref document: CA |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06837763 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006316609 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008541338 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006316609 Country of ref document: AU Date of ref document: 20061116 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2315/KOLNP/2008 Country of ref document: IN |